510(k) K100917
K100917 is an FDA 510(k) premarket notification submitted by Biomedical Diagnostics (Bmd) SA for the device "FIDIS VASCULITIS ASSAY KIT AND ANALYZER AND CARIS SYSTEM". The FDA issued a decision of Substantially Equivalent on November 3, 2010. The device falls under product code MOB (Test System, Antineutrophil Cytoplasmic Antibodies (Anca)), a Class II device regulated under 21 CFR 866.5660. Biomedical Diagnostics (Bmd) SA has at least 9 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- November 3, 2010
- Date Received
- April 2, 2010
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Test System, Antineutrophil Cytoplasmic Antibodies (Anca)
- Device Class
- Class II
- Regulation Number
- 866.5660
- Review Panel
- IM
- Submission Type